1. Therapeutic role of miR-26a on cardiaorenal injury in mice model of angiotensin-II induced chronic kidney disease through inhibition of LIMS1/ILK pathway
   Weijie Ni et al, 2024, Chinese Medical Journal CrossRef
2. Genetically engineered loaded extracellular vesicles for drug delivery
   Zuriñe Erana-Perez et al, 2024, Trends in Pharmacological Sciences CrossRef
3. Engineering Approaches for Exosome Cargo Loading and Targeted Delivery: Biological versus Chemical Perspectives
   Waqas Ahmed et al, 2024, ACS Biomaterials Science & Engineering CrossRef
4. Exosomes on the development and progression of renal fibrosis
   Peihan Wang et al, 2024, Cell Proliferation CrossRef
5. Therapeutic potential: The role of mesenchymal stem cells from diverse sources and their derived exosomes in diabetic nephropathy
   Lixin Liu et al, 2024, Biomedicine & Pharmacotherapy CrossRef
6. Fibrosis in Chronic Kidney Disease: Pathophysiology and Therapeutic Targets
   Allison B. Reiss et al, 2024, Journal of Clinical Medicine CrossRef
7. MicroRNA‐26a alleviates tubulointerstitial fibrosis in diabetic kidney disease by targeting PAR4
   Gaoting Qu et al, 2024, Journal of Cellular and Molecular Medicine CrossRef
8. Pharmacokinetic–pharmacodynamic modeling of the active components of Shenkang injection in rats with chronic renal failure and its protective effect on damaged renal cells
   Lin Zhou et al, 2023, Biopharmaceutics & Drug Disposition CrossRef